Á lódáil...
Delafloxacin: design, development and potential place in therapy
Delafloxacin (DLX) is a new fluoroquinolone pending approval, which has shown a good in vitro and in vivo activity against major pathogens associated with skin and soft tissue infections and community-acquired respiratory tract infections. DLX also shows good activity against a broad spectrum of mic...
Na minha lista:
| Foilsithe in: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Dove Medical Press
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367733/ https://ncbi.nlm.nih.gov/pubmed/28356714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S106071 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|